Home › Obesity › Texas › McKinney
Obesity clinical trials in McKinney, TX
4 studies for Obesity are looking for participants at sites in and around McKinney (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RecruitingPhase 2
- Revival Research Institute, LLC, McKinney
- Texas Institute of Cardiology, PA, McKinney
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
RecruitingPhase 3
- North Dallas Research Associates, McKinney
- Texas Institute of Cardiology, McKinney
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
RecruitingPhase 3
- Texas Institute of Cardiology, McKinney
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
RecruitingPhase 3
- North Texas Research Associates, McKinney
About Obesity
Read about the causes of obesity and find out what you can do to decrease your risk of its associated health issues.
More about Obesity on MedlinePlus
Obesity trials in other cities
- Houston, TX44 studies
- Chicago, IL42 studies
- New York City, NY40 studies
- San Antonio, TX39 studies
- Washington, DC33 studies
- Dallas, TX31 studies
- Orlando, FL29 studies
- Boston, MA28 studies
- Miami, FL27 studies
- Las Vegas, NV27 studies
- Atlanta, GA25 studies
- Jacksonville, FL25 studies
Other studies in McKinney
- Heart Failure7 studies
- Type 2 Diabetes6 studies
- Asthma5 studies
- COPD5 studies
- Cardiovascular Disease4 studies
- Chronic Kidney Disease4 studies
- Atherosclerosis3 studies
- Atrial Fibrillation3 studies
- Interstitial Lung Diseases3 studies
- Graves Disease3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.